Molecular Pathogenesis and Emerging Therapeutic Targets and Strategies in Huntington’s Disease

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 31 May 2026

Special Issue Editors


E-Mail Website
Guest Editor
Department of Biochemistry and Molecular Biology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary
Interests: molecular pathogenesis of neurodegeneration; Huntington’s disease; Alzheimer’s disease; transcriptomics; miRNAs; epigenetic regulation of transcription; histone variants and histone modifications; animal models
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Genetics, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary
Interests: genetics; gene expression regulation; chromatin biology; histone modifications; miRNAs; neurodegeneration
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The gene mutation responsible for Huntington’s disease (HD), a fatal, inherited neurodegenerative disorder, was identified more than three decades ago. The tremendous amount of work invested in better understanding the molecular mechanisms of this disorder during this period finally seems to be paying off; more and more pieces of the puzzle are falling into place, paving the way for disease-modifying therapeutic strategies. The mutation in the huntingtin gene is an expansion of a CAG trinucleotide repeat that results in an expanded polyglutamine repeat in the mutant protein (mHTT). This change leads to a gain-of-function mutation that negatively affects several crucial cellular processes, including proteostasis, transcription regulation, and mitochondrial functions. A better understanding of these processes is needed, however, to fully elucidate how they lead to progressive, cell-type-specific neurodegeneration. Recent encouraging advances in the development of therapeutic strategies include RNA-targeting therapies that reduce mutant HTT expression, CRISPR/Cas approaches for gene editing, and small-molecule enhancers of autophagy. Translating preclinical results into successful therapies while preserving wild-type HTT functions, however, remains a challenge.

In this Special Issue, we welcome research articles and reviews focusing on the pathogenesis and therapy of HD.

Dr. Laszlo Bodai
Dr. Nora Zsindely
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Huntington’s disease
  • huntingtin
  • polyglutamine
  • neurodegeneration
  • pathogenesis
  • therapeutic targets
  • proteopathy
  • autophagy dysfunction
  • transcriptional dysregulation
  • mitochondrial dysfunction

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop